ストックスクリーナーアプリを入手
3.475
3.20%
0.055
Rocket Pharmaceuticals Inc (RCKT) 最新ニュース
Will Rocket Pharmaceuticals Inc. Equity Warrant stock benefit from upcoming earnings reportsJuly 2025 Highlights & Community Supported Trade Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Rocket Pharmaceuticals, Inc. (RCKT) Investors to Inquire about Securities Investigation - ACCESS Newswire
Is Rocket Pharmaceuticals Inc. Equity Warrant stock bottoming outQuarterly Risk Review & Free Real-Time Market Sentiment Alerts - newser.com
Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Will Rocket Pharmaceuticals Inc. stock go up soonJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com
Should you hold or exit Rocket Pharmaceuticals Inc. now2025 Trading Volume Trends & Real-Time Buy Signal Notifications - newser.com
Published on: 2025-10-10 06:17:17 - newser.com
Rocket Pharmaceuticals (NASDAQ:RCKT) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Published on: 2025-10-10 04:39:16 - newser.com
Building trade automation scripts for Rocket Pharmaceuticals Inc. Equity Warrant2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
How to use Fibonacci retracement on Rocket Pharmaceuticals Inc. Equity WarrantMarket Volume Report & High Win Rate Trade Alerts - newser.com
How sentiment analysis helps forecast Rocket Pharmaceuticals Inc. Equity WarrantPortfolio Update Report & Weekly High Potential Stock Alerts - newser.com
Will Rocket Pharmaceuticals Inc. (9IP1) stock profit from fiscal stimulusEarnings Beat & Intraday High Probability Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Investors to Reach Out - ACCESS Newswire
How to manage a losing position in Rocket Pharmaceuticals Inc. Equity Warrant2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-09 05:44:17 - newser.com
Published on: 2025-10-09 03:18:17 - newser.com
Can a trend reversal in Rocket Pharmaceuticals Inc. Equity Warrant lead to recovery2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - newser.com
Automated trading signals detected on Rocket Pharmaceuticals Inc. Equity WarrantWeekly Market Report & Safe Entry Point Identification - newser.com
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Pass Below 50-Day Moving AverageWhat's Next? - MarketBeat
What drives Rocket Pharmaceuticals Inc stock priceBollinger Bands Signals & Free Dynamic Capital Growth - earlytimes.in
Rocket Pharmaceuticals Pulls BLA for Fanconi Anemia Gene Therapy RP-L102 - CGTLive®
How Rocket Pharmaceuticals Inc. Equity Warrant stock reacts to global recession fearsJuly 2025 Trends & Risk Controlled Daily Trade Plans - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock ready for a breakout2025 Trading Recap & Verified Swing Trading Watchlists - newser.com
Rocket Pharmaceuticals Inc. Equity Warrant stock volume spike explainedPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com
Using AI based signals to follow Rocket Pharmaceuticals Inc. Equity WarrantMarket Performance Summary & Weekly High Conviction Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Stockholders to Reach Out - ACCESS Newswire
Combining price and volume data for Rocket Pharmaceuticals Inc. Equity WarrantEarnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
Real time social sentiment graph for Rocket Pharmaceuticals Inc. Equity WarrantTrade Signal Summary & Daily Chart Pattern Signal Reports - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock positioned well for digital economyGap Up & Community Verified Trade Signals - newser.com
Understanding Rocket Pharmaceuticals Inc. Equity Warrant’s price movementJuly 2025 PreEarnings & Accurate Intraday Trade Tips - newser.com
Is now a turning point for Rocket Pharmaceuticals Inc.2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Published on: 2025-10-05 06:51:42 - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock resilient to inflationMarket Activity Report & Real-Time Volume Spike Alerts - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock a buy for dividend portfolios2025 Retail Activity & Safe Entry Zone Identification - newser.com
Comparing Rocket Pharmaceuticals Inc. Equity Warrant in custom built stock radarsJuly 2025 WrapUp & Weekly Sector Rotation Insights - newser.com
Rocket Pharmaceuticals board member Pedro Granadillo resigns - StreetInsider
Leerink Partners Maintains Rocket Pharmaceuticals (RCKT) Market Perform Recommendation - Nasdaq
Rocket Pharmaceuticals announces board resignation of Pedro Granadillo - Investing.com
Rocket Pharmaceuticals Pulls FDA Filing for Rare Blood Disorder Gene Therapy - MedCity News
Rocket Pharmaceuticals (RCKT) Withdraws U.S. Filing for Gene The - GuruFocus
Leerink Partners Adjusts Rocket Pharmaceuticals Price Target to $7 From $9, Maintains Market Perform Rating - MarketScreener
Rocket Pharma pulls BLA for gene therapy RP-L102 in the USA - The Pharma Letter
Rocket Pharma Stock Gets A Price Target Cut After Withdrawing FDA Application For Rare Bone Marrow Disorder Gene Therapy - Stocktwits
Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Cut to $7.00 by Analysts at Leerink Partners - MarketBeat
RCKT: Analyst Lowers Price Target for Rocket Pharmaceuticals | R - GuruFocus
Leerink Partners Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating, Announces Target Price $7 - 富途牛牛
Rocket Pharmaceuticals (RCKT) Halts U.S. Application for Gene Th - GuruFocus
Using R and stats models for Rocket Pharmaceuticals Inc. Equity Warrant forecasting2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
Rocket Pharmaceuticals withdraws US application for blood disorder gene therapy - MarketScreener
Rocket Pharmaceuticals withdraws BLA for gene therapy RP-L102 in the US - Investing.com
Rocket Pharmaceuticals withdraws US application of gene therapy for rare blood disorder - Yahoo
Rocket Pharmaceuticals withdraws gene therapy application from FDA - StreetInsider
Will Rocket Pharmaceuticals Inc. rebound enough to break evenSell Signal & AI Enhanced Trade Execution Alerts - newser.com
Will Rocket Pharmaceuticals Inc. (9IP1) stock outperform small cap peers2025 Buyback Activity & Target Return Focused Picks - newser.com
2.36%
0.82%
大文字化:
|
ボリューム (24 時間):